Your shopping cart is currently empty

Orotidine 5′-monophosphate, a pyrimidine ribonucleoside, functions as an endogenous metabolite in human, E. coli, and mouse processes. It serves as an intermediate in uridine monophosphate (UMP) biosynthesis and is utilized in researching the mechanism of orotidine 5′-monophosphate decarboxylase.

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 5 mg | Inquiry | Inquiry | Inquiry |
| Description | Orotidine 5′-monophosphate, a pyrimidine ribonucleoside, functions as an endogenous metabolite in human, E. coli, and mouse processes. It serves as an intermediate in uridine monophosphate (UMP) biosynthesis and is utilized in researching the mechanism of orotidine 5′-monophosphate decarboxylase. |
| In vitro | Orotidine 5′-monophosphate is synthesized from orotate and phosphoribosyl pyrophosphate by the enzyme orotate phosphoribosyltransferase. The enzyme UMP synthase subsequently converts OMP into uridine 5′-monophosphate [1]. |
| Synonyms | Orotidylicacid, Orotidine monophosphate, Orotidine 5′-monophosphate |
| Molecular Weight | 368.191 |
| Formula | C10H13N2O11P |
| Cas No. | 2149-82-8 |
| Smiles | O[C@@H]1[C@@H](COP(O)(O)=O)O[C@H]([C@@H]1O)n1c(cc(=O)[nH]c1=O)C(O)=O |
| Relative Density. | 2.000 g/cm3 (Predicted) |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
Dissolve 2 mg of the compound in 100 μL DMSO
to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.
1) Add 100 μL of the DMSO
stock solution to 400 μL PEG300
and mix thoroughly until the solution becomes clear.
2) Add 50 μL Tween 80 and mix well until fully clarified.
3) Add 450 μL Saline,PBS or ddH2O
and mix thoroughly until a homogeneous solution is obtained.
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.